Jakob Lykke
Overview
Explore the profile of Jakob Lykke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gogenur I, Justesen T, Tarpgaard L, Bulut M, Hansen T, Jensen L, et al.
Ann Surg
. 2024 Dec;
PMID: 39692004
Objective: This clinical trial investigated the safety and efficacy of single-cycle pembrolizumab in patients with localized deficient mismatch repair (dMMR) colon cancer. Background: Neoadjuvant immunotherapy has induced remarkable rates of...
2.
Hein Nordvig E, Bergliot Gronbaek G, Khalid Al-Uboody Z, Lykke J, Hagen Vasehus Schou J, Ostergaard Poulsen L
Clin Colorectal Cancer
. 2024 Nov;
24(1):64-71.
PMID: 39510905
Introduction: Total neoadjuvant treatment (TNT) with induction chemotherapy (ICT) followed by chemoradiotherapy (CRT) has improved long-term outcomes for patients with locally advanced rectal cancer (LARC). However, long-term outcomes have not...
3.
Kays Mohammed Ali Y, Dolin T, Damm Nybing J, Lykke J, Linden F, Hogh-Schmidt E, et al.
Int J Obes (Lond)
. 2024 Jan;
48(4):533-541.
PMID: 38172335
Background: Excess abdominal visceral adipose tissue (VAT) is associated with metabolic diseases and poor survival in colon cancer (CC). We assessed the impact of different types of CC surgery on...
4.
Eefsen R, Larsen J, Klarskov L, Altaf R, Hogdall E, Ingeholm P, et al.
Int J Cancer
. 2023 Jan;
152(10):2145-2152.
PMID: 36594580
Therapy with immune checkpoint inhibitors (ICI) is effective in patients with metastatic mismatch-repair deficient (dMMR) colorectal cancer (CRC); however, data on treatment with neoadjuvant ICI in patients with locally advanced...
5.
Dohrn N, Oppermann C, Yikilmaz H, Laursen M, Khesrawi F, Clausen F, et al.
Langenbecks Arch Surg
. 2022 Sep;
407(8):3577-3586.
PMID: 36171282
Purpose: Previous studies have shown that intracorporeal anastomosis (ICA) in minimally invasive right colectomy may improve postoperative recovery compared with extracorporeal anastomosis (ECA). It has been hypothesized that creating the...
6.
Dolin T, Christensen I, Lund C, Bojesen S, Lykke J, Nielsen D, et al.
Eur J Surg Oncol
. 2022 Sep;
49(1):244-251.
PMID: 36137882
Introduction: Aging is often associated with low-grade chronic inflammation and a senescent immune system. Vitamin D is a regulator of immune function, and low plasma vitamin D is associated with...
7.
Dohrn N, Yikilmaz H, Laursen M, Khesrawi F, Clausen F, Sorensen F, et al.
Ann Surg
. 2022 Feb;
276(5):e294-e301.
PMID: 35129520
Objective: To determine if minimally invasive right colectomy with intra-corporeal anastomosis improves postoperative recovery compared to extra-corporeal anastomosis. Background: Previous trials have shown that intracorporeal anastomosis improves postoperative recovery; however,...
8.
Juvik A, Nielsen S, Tolstrup M, Lykke J, Klein M
Dan Med J
. 2020 Aug;
67(9).
PMID: 32800067
Introduction: The present study aimed to evaluate the anastomotic leakage rate in relation to anastomotic technique in right hemicolectomy in a single high-volume centre. Methods: This was a retrospective single-centre...
9.
Lykke J, Roikjaer O, Jess P, Rosenberg J
Ann Coloproctol
. 2020 Feb;
36(5):316-322.
PMID: 32079050
Purpose: This study aimed to identify possible patient- and tumor-related factors associated with risk of TNM stage III disease in nonmetastatic colon cancer. Methods: The associations between stage III disease...
10.
Lykke J, Rosenberg J, Jess P, Roikjaer O
World J Surg Oncol
. 2019 Apr;
17(1):62.
PMID: 30940175
Background: It has been suggested that apart from tumour and nodal status, a range of patient-related and histopathological factors including lymph node yield and tumour location seems to have prognostic...